AI assistant
Bayer CropScience Limited. — Regulatory Filings 2021
Aug 13, 2021
61408_rns_2021-08-13_656e5c27-0fbf-4a09-902e-dcf18ca57e73.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [90 x 91] intentionally omitted <==
August 13, 2021
The General Manager Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001
SECURITY ID : BAYERCROP SECURITY CODE : 506285
Dear Sir / Madam,
Sub.: Change in the composition of the Board of Directors and Key Managerial Personnel of the Company.
This is to inform BSE Limited that at the meeting of the Board of Directors of Bayer CropScience Limited (“the Company”) held on Friday, August 13, 2021, the following items inter-alia were noted, considered and approved:
-
a) Resignation of Mr. Rolf Hoffmann (DIN: 08460583) as an Executive Director and Chief Financial Officer of the Company with effect from August 31, 2021 .
-
b) Appointment of Mr. Simon Britsch (DIN: 09194547) as an Additional Director with effect from September 01, 2021 and designated as WholeTime Director and Chief Financial Officer of the Company with effect from September 01, 2021 , subject to the approval of the shareholders and statutory authorities, as applicable.
Bayer CropScience Ltd. CIN: L24210MH1958PLC011173
Registered and Corporate Office: Bayer House Central Avenue Hiranandani Estate Thane (West) – 400 607 Maharashtra, India
Tel : +91 22 2531 1234 Fax : +91 22 2545 5063 www.bayer.in
www.cropscience.bayer.com
Information as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is given in the Annexure I.
Request you to kindly update your records.
Thanking you.
Yours faithfully, for Bayer CropScience Limited
Digitally signed by NIKUNJKUMAR JAYSUKHLAL SAVALIYA NIKUNJKUMAR DN: c=IN, st=Gujarat, 2.5.4.20=f4b6303c6a9fe05eb04e62759179373cbcf4b728c73ed8032294 e09b9e3e0c98, postalCode=390024, street=102 TITHI FLATS, BHADRAN JAYSUKHLAL NAGAR, NEW SAMA ROAD, CHHANI RD, VADODARA, serialNumber=d3cad62ac6fcdd76e7d78a49dee85262351ff6c69d1c3b8 4d7669f10a495714a, o=Personal, cn=NIKUNJKUMAR JAYSUKHLAL SAVALIYA SAVALIYA, pseudonym=edc1463c7f2e505c0cb80b5170d37433 Date: 2021.08.13 20:18:03 +05'30'
Nikunjkumar Savaliya
Company Secretary & Compliance Officer
RESTRICTED
==> picture [90 x 91] intentionally omitted <==
Annexure I
Information about change in Board Composition and Key Managerial Personnel.
| Reason for change viz. appointment, resignation, removal, death or otherwise |
1) Mr. Rolf Hoffmann will be taking over the responsibilities within Consumer Health Division of Bayer in North America with effect from September 01, 2021. In view of the new responsibility, Mr. Hoffmann has resigned as an Executive Director and Chief Financial Officer of the Companyw.e.f. August 31, 2021. 2) Mr. Simon Britsch is appointed as an Additional Director, designated as Whole Time Director and Chief Financial Officer of the Company w.e.f. September 01, 2021. |
|---|---|
| Date of appointment/ cessation (as applicable) & term of appointment |
1) Date of Resignation of Mr. Rolf Hoffmann is with effect fromAugust 31, 2021. 2) Date of Appointment of Mr. Simon Britsch is with effect fromSeptember 01, 2021. |
| Brief Profile (in case of appointment) |
Brief Profile: Mr. Simon Britsch: Simon Britsch started his career with Bayer AG as a Commercial Trainee in the year 2000. In 2005, he moved to Corporate Audit as an Auditor and SOX Coordinator. From 2009 until 2012 he was the Chief Financial Officer of Bayer Vietnam. He subsequently moved to China, assuming the role of Head of Business Excellence for Bayer Healthcare. Simon returned to Bayer AG in 2016, where he was leading the global Enterprise Risk Management & Business Continuity Management function. Simon holds an MBA from Instituto de Empresa in Spain as well as a bachelor’s degree in Economics and Management from FOM University of Applied Sciences in Germany. Moreover, he is an alumnus of Harvard Business School. |
| Disclosure of relationships between directors (in case of appointment of a director) |
None of the Directors are related to each other personally, financially or otherwise. |
RESTRICTED